1. Home
  2. YDES vs MGIC Comparison

YDES vs MGIC Comparison

Compare YDES & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDES
  • MGIC
  • Stock Information
  • Founded
  • YDES 2013
  • MGIC 1983
  • Country
  • YDES Taiwan
  • MGIC Israel
  • Employees
  • YDES N/A
  • MGIC N/A
  • Industry
  • YDES
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • YDES
  • MGIC Technology
  • Exchange
  • YDES Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • YDES 1.1B
  • MGIC 990.3M
  • IPO Year
  • YDES N/A
  • MGIC 1991
  • Fundamental
  • Price
  • YDES $9.17
  • MGIC $22.46
  • Analyst Decision
  • YDES
  • MGIC Buy
  • Analyst Count
  • YDES 0
  • MGIC 2
  • Target Price
  • YDES N/A
  • MGIC $18.00
  • AVG Volume (30 Days)
  • YDES 84.2K
  • MGIC 34.0K
  • Earning Date
  • YDES 09-30-2025
  • MGIC 11-18-2025
  • Dividend Yield
  • YDES N/A
  • MGIC 2.75%
  • EPS Growth
  • YDES N/A
  • MGIC 10.08
  • EPS
  • YDES N/A
  • MGIC 0.77
  • Revenue
  • YDES $510,360.00
  • MGIC $1,013,154,000.00
  • Revenue This Year
  • YDES N/A
  • MGIC $11.72
  • Revenue Next Year
  • YDES N/A
  • MGIC $6.24
  • P/E Ratio
  • YDES N/A
  • MGIC $29.96
  • Revenue Growth
  • YDES 45.76
  • MGIC 89.20
  • 52 Week Low
  • YDES $5.30
  • MGIC $10.70
  • 52 Week High
  • YDES $31.00
  • MGIC $24.94
  • Technical
  • Relative Strength Index (RSI)
  • YDES N/A
  • MGIC 56.86
  • Support Level
  • YDES N/A
  • MGIC $23.51
  • Resistance Level
  • YDES N/A
  • MGIC $24.90
  • Average True Range (ATR)
  • YDES 0.00
  • MGIC 0.81
  • MACD
  • YDES 0.00
  • MGIC 0.11
  • Stochastic Oscillator
  • YDES 0.00
  • MGIC 49.50

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

Share on Social Networks: